PCA SKIN Launches Microbiome-Focused Acne Control Cleanser
Key Takeaways
- PCA SKIN launched Acne Control Prebiotic Gel Cleanser on September 1, positioning the product as a microbiome-supportive approach to cleansing acne-prone skin.
- The formulation combines 2% salicylic acid with 1% azelaic acid, 1% niacinamide, and a proprietary combination of prebiotic and postbiotic ingredients.
- Claims regarding selective effects on acne-associated bacteria, prevention of rebound oiliness, and the patent-pending Triple Biotic Technology require supporting clinical or technical data before publication as established findings.
PCA SKIN has launched Acne Control Prebiotic Gel Cleanser, a new daily cleanser formulated to address acne while supporting the skin barrier and microbiome, according to information provided by the company.
The cleanser, launched September 1, combines 2% salicylic acid with 1% azelaic acid and 1% niacinamide. PCA SKIN states that salicylic acid exfoliates dead skin cells and helps clear pore-clogging debris, while azelaic acid is included to address visible redness and post-blemish marks. Niacinamide is intended to help manage excess surface oil.
Triple Biotic Technology Targets the Skin Microbiome
The formulation also incorporates what PCA SKIN calls its patent-pending Triple Biotic Technology. According to the company, the system combines inulin, a prebiotic; Lactobacillus ferment, described as a postbiotic; and butyloctanol, which the company characterizes as a “smart” biotic.
PCA SKIN says the combination was developed to preserve beneficial microorganisms while inhibiting bacteria associated with acne and supporting the skin’s moisture barrier. The company positions the cleanser as an alternative to more stripping acne-cleansing approaches, with the goal of removing excess surface oil without leaving skin feeling tight or dry.